The nation's largest Latino civil rights organization, UnidosUS, along with 12 other state and national organizations, have filed a complaint with the HHS Office of Civil Rights regarding what they say is Florida's "illegal discrimination" under the Civil Rights Act…
Payer
Weight loss drugs like Ozempic and other GLP-1s exploded in popularity this year, resulting in drug shortages and increasing costs for payers and employers.
Additional Medicaid coverage enacted during the COVID-19 pandemic helped keep the number of uninsured people down at record lows in 2022 even as poverty levels soared, according to a Sept. 12 New York Times report.
From payers announcing cuts, to a lawmaker investigation denials, here are five updates about prior authorizations Becker's reported since Aug. 17:
Mississippi could consider Medicaid expansion next year, Mississippi Rep. Jason White told Mississippi Today.
Advertisement
The majority of older adults say they would stick with their current Medicare plan rather than switch to a different plan when they feel they have too many options, a survey from the Commonwealth Fund found.
Humana offers the best Medicare supplement plan in 2023, according to a ranking published Sept. 7 by Forbes Health.
Elevance Health is seeking to block a former regional Medicare president from taking a similar role at Molina Healthcare, alleging the former executive is in possession of trade secrets that would inevitably be disclosed to Molina.
Medicaid spent $1.1 billion on Ozempic and other GLP-1 drugs that can be used for weight loss in 2022, a KFF analysis published Sept. 8 found.
Much of Medicare Advantage growth is driven by people switching to the program from traditional Medicare, and this growth is picking up speed in rural areas.